The resolution expresses concern over rising health care costs in Missouri and emphasizes the need for improved affordability for families and communities. It highlights the burden that American patients bear in subsidizing low-cost prescription drugs for wealthier foreign nations and supports the initiatives taken by President Trump to enhance health care affordability while maintaining U.S. leadership in medical innovation. The resolution specifically endorses the TrumpRx platform, which aims to provide American patients with lower prescription drug prices and greater transparency by bypassing traditional supply chain intermediaries.

Furthermore, the resolution calls for the U.S. Department of Health and Human Services to prevent discriminatory practices by health insurance plans and pharmacy benefits managers, ensuring that all patient-paid prescription drug costs, including those from TrumpRx, count towards deductibles and out-of-pocket maximums. It also urges health insurers to adopt similar policies and requests the Missouri Department of Health and Senior Services to evaluate the GENEROUS Model for potential cost savings in the state's Medicaid program. The resolution concludes with instructions to prepare copies for key federal and state officials.